Meso Emerging Active

Novartis acquires biotech firm Excellergy

New narrative with limited coverage — still forming.

Score
0.2
Velocity
▲ 0.0
Articles
3
Sources
2

Sentiment Timeline

Event Timeline

Apr 02, 2026
Novartis AG (NVS) Announces Final Two-Year Results From Phase III APPLAUSE‑IgAN Study Neutral
Mar 31, 2026
Centessa Pharmaceuticals Stock Soars 45% Over Acquisition Deal With Eli Lilly And … Bullish
Mar 28, 2026
Novartis to buy U.S.-based biotech firm Excellergy for up to $2 billion Neutral

Timeline

First SeenMar 28, 2026
Last UpdatedMar 28, 2026